Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Immune Checkpoint Inhibitors and Iga Nephropathy; a Rare Side Effect Publisher



Md Mobarakeh Maryam DEHGHANI ; Ar Maghsoudi Ahmad REZA
Authors

Source: Journal of Nephropharmacology Published:2025


Abstract

The pathophysiological mechanisms of secondary IgA nephropathy (IgAN) containing IgA-mediated immune complex deposition in the glomeruli. However, the specific triggers can vary widely, including infections, liver disease, and malignancies, in addition to drug-induced factors. IgAN is a rare however is a serious complication of immune checkpoint inhibitor (ICI) therapy that can lead to acute kidney injury. Clinically, the diagnosis of sIgAN typically follows a temporal association between medication administration and the onset of renal symptoms, such as hematuria or proteinuria. A kidney biopsy is often necessary to confirm the diagnosis and rule out other causes of nephropathy. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
11. Covid-19 and the Kidney; Mechanisms of Tubular Injury by Sars-Cov-2, Journal of Renal Injury Prevention (2021)
17. Renin-Angiotensin System and Unilateral Ureteral Obstruction, Physiology and Pharmacology (Iran) (2017)
20. Macrophage Activation Syndrome: A Review of Recent Renal Findings, Journal of Renal Injury Prevention (2024)